DOLF researchers announce initiation of a major a new clinical trial of treatments for onchocerciasis in Liberia. The study will compare the safety and efficacy of three new combination treatments with a reference treatment of albendazole plus ivermectin. DOLF researchers have worked closely for the past 18 months with colleagues at the National Public Health […]
The DOLF Project has Initiated a Clinical Trial of New Treatments for Onchocerciasis in Liberia
![](https://dolfproject.wustl.edu/files/2024/04/Liberia_Group_2024-1838cfd962c2aeb6-350x263.jpg)